OverviewSuggest Edit
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. It operates in three core business units: Specialty Care, Vaccines, and General Medicines. The Specialty Care business unit focuses on rare diseases, multiple sclerosis, oncology, immunology, and rare blood disorders. The Vaccines business unit primarily operates through Sanofi Pasteur, a key supplier of life-saving vaccines in both developed and emerging markets. The General Medicines business unit offers treatments for diabetes, cardiovascular, as well as established products. The company also comprises Consumer Healthcare (CHC), a standalone business unit with integrated research, development, manufacturing, support, and information technology capabilities.
| Type | Public | |
| Founded | 2004 | |
| HQ | Paris, FR | Map |
| Website | sanofi.com | |
| Employee Ratings | More | |
| Overall Culture | B | More |
Recent NewsAll News
- Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
- White House to allow AstraZeneca, Novavax, Sanofi to distribute COVID-19 shots how they see fit
- Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects
- Worldwide Active Pharmaceutical Ingredients (API) Industry to 2026 - Key Players Include Pfizer, Novartis and Sanofi Among Others
Key People/Management at Sanofi
Paul Hudson
Serge Weinberg
Olivier Charmeil
Natalie Bickford
Karen Linehan
Philippe Luscan
Sanofi Office Locations
Sanofi Financials and Metrics
Sanofi Revenue
| EUR | |
|---|---|
Revenue (FY, 2020) | 36.0b |
Revenue growth (FY, 2019 - FY, 2020), % | (0.2%) |
Gross profit (FY, 2020) | 25.2b |
Gross profit margin (FY, 2020), % | 70% |
Net income (FY, 2020) | 12.4b |
EBIT (FY, 2020) | 14.1b |
Market capitalization (11-Jun-2021) | 111.0b |
Closing stock price (11-Jun-2021) | 88.9 |
Cash (31-Dec-2020) | 13.9b |
EV | 120.8b |
| EUR | FY, 2017 |
|---|---|
EV/EBIT | 18.5 x |
EV/CFO | 14.6 x |
Revenue/Employee | 329.0k |
Debt/Equity | 0.3 x |
Debt/Assets | 0.2 x |
Financial Leverage | 1.7 x |
P/E Ratio | 12.3 |
Sanofi Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Kiadis Pharma | November 02, 2020 | €308 m |
| Principia BioPharma | August 17, 2020 | $3.4 b |
| Synthorx | December 09, 2019 | $2.5 m |
| Ablynx | January 29, 2018 | $4.8 b |
| Bioverativ | January 22, 2018 | $11.6 b |
| Aventis S.A. | August 30, 2004 | |
| Ablynx N.V. | ||
| Allston Landing Limited Partnership | ||
| A. Nattermann & Cie. GmbH | ||
| AO Sanofi Russia |
Sanofi Revenue Breakdown
Sanofi revenue breakdown by business segment: 16.6% from Vaccines, 71.2% from Pharmaceuticals and 12.2% from Consumer Healthcare
Sanofi revenue breakdown by geographic segment: 39.0% from North America, 35.6% from Other Countries and 25.4% from Europe
Sanofi Cybersecurity Score
Sanofi Environment, Social & Governance (ESG) Ratings
Sanofi Online and Social Media Presence
141.07k Twitter followers
Sanofi has 141.07k Twitter Followers. The number of followers has decreased 0.1% month over month and increased 2% quarter over quarter
Sanofi's Trends
Twitter Engagement Stats for @sanofi
6.6k
Tweets
249
Following
141.1k
Followers
46
Tweets last 30 days
22.2
Avg. likes per Tweet
97.8%
Tweets with engagement
Sanofi Company Culture
Overall Culture
B
71/100
CEO Rating
B
70/100
Compensation
B+
75/100
Diversity
B+
73/100
Sanofi News and Updates
Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
White House to allow AstraZeneca, Novavax, Sanofi to distribute COVID-19 shots how they see fit
Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects
Worldwide Active Pharmaceutical Ingredients (API) Industry to 2026 - Key Players Include Pfizer, Novartis and Sanofi Among Others
Sanofi and Merck's first and only six-in-one pediatric combination vaccine now available in the United States
New Covid-19 Vaccine Will Be Produced This Year As Sanofi, GSK Launch Phase 3 Trial
Sanofi Frequently Asked Questions
When was Sanofi founded?
Sanofi was founded in 2004.
Who are Sanofi key executives?
Sanofi's key executives are Paul Hudson, Serge Weinberg and Olivier Charmeil.
How many employees does Sanofi have?
Sanofi has 100,409 employees.
What is Sanofi revenue?
Latest Sanofi annual revenue is €36 b.
What is Sanofi revenue per employee?
Latest Sanofi revenue per employee is €358.9 k.
Who are Sanofi competitors?
Competitors of Sanofi include Viatris, AstraZeneca and Eli Lilly.
Where is Sanofi headquarters?
Sanofi headquarters is located at 54, rue La Boétie, Paris.
Where are Sanofi offices?
Sanofi has offices in Paris, Ambarès-et-Lagrave, Amilly, Antony and in 108 other locations.
How many offices does Sanofi have?
Sanofi has 120 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies